09.09.2017 13:56:00
|
TINTRI (TNTR) ALERT: Johnson Fistel, LLP Announces Investigation of Tintri, Inc.; Encourages Investors to Contact the Firm for Information
SAN DIEGO, Sept. 9, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP (formerly Johnson & Weaver, LLP) is investigating potential violations of the federal securities laws by Tintri, Inc. (NASDAQ: TNTR) and certain of its officers. Tintri develops and markets an enterprise cloud platform, combining cloud management software technology and a range of all-flash storage systems for virtualized and cloud environments in the United States and internationally.
Specifically, Johnson Fistel's investigation seeks to determine whether certain statements regarding Tintri's business and prospects were false and misleading when made.
On June 30, 2017, Tintri stock opened for trading at $7.12, the day the Company sold 8.6 million shares of stock in its initial public stock offering (the "IPO"), reaching a high of $7.75 per share that day.
On September 7, 2017, Tintri reported results for its second quarter ending July 31, 2017. Revenue came in at the low end of analyst expectations and third quarter guidance, was much weaker than expected. Tintri now projects revenues to increase just slightly quarter over quarter to $36-37 million compared to analysts' expectations of $42.5 million. Following the news, Tintri stock has plummeted, closing down 31.89% at $4.55 on September 8, 2017.
If you have information that could assist in this investigation, or if you are a Tintri shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonfistel.com) by email or by phone at 619-814-4471. If emailing, please include a phone number.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
View original content:http://www.prnewswire.com/news-releases/tintri-tntr-alert-johnson-fistel-llp-announces-investigation-of-tintri-inc-encourages-investors-to-contact-the-firm-for-information-300516698.html
SOURCE Johnson Fistel, LLP
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
04.02.25 |
Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks (Financial Times) | |
04.02.25 |
AKTIEN IM FOKUS: Ausblick bringt Merck & Co unter Druck - Pfizer auch im Minus (dpa-AFX) | |
04.02.25 |
ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar (dpa-AFX) | |
04.02.25 |
Pfizer vermeldet Umsatzsprung - Aktie dennoch schwächer (dpa-AFX) | |
04.02.25 |
S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte ein Pfizer-Investment von vor 5 Jahren eingebracht (finanzen.at) | |
04.02.25 |
Ausblick: Pfizer stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
28.01.25 |
S&P 500-Wert Pfizer-Aktie: So viel Verlust hätte eine Investition in Pfizer von vor 3 Jahren bedeutet (finanzen.at) | |
21.01.25 |
S&P 500-Papier Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor einem Jahr verloren (finanzen.at) |
Analysen zu Pfizer Inc.mehr Analysen
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG | |
05.02.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
04.02.25 | Pfizer Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Pfizer Inc. | 25,11 | 1,15% |
|
Tintri Inc Registered Shs | 0,00 | -98,00% |
|